Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Protein Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT01274403
What this trial is testing

Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gruppo Italiano Studio Linfomi 130
Testing effectiveness (Phase 2)Looking for participantsNCT04991103
What this trial is testing

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

Who this might be right for
Multiple MyelomaAmyloidosis
University of Alabama at Birmingham 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060627
What this trial is testing

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

Who this might be right for
Relapsed Multiple Myeloma
PETHEMA Foundation 60
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430894
What this trial is testing

KRDI in Transplant-Eligible MM

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT03457142
What this trial is testing

Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Roswell Park Cancer Institute 15
Early research (Phase 1)Ended earlyNCT03755154
What this trial is testing

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple Myeloma+1 more
Institut de Recherches Internationales Servier 60
Testing effectiveness (Phase 2)Ended earlyNCT00790842
What this trial is testing

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
PrECOG, LLC. 63
Early research (Phase 1)Study completedNCT00000986
What this trial is testing

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Large-scale testing (Phase 3)UnknownNCT03578341
What this trial is testing

Oral Colostrum and Its Effect on Immune System

Who this might be right for
Immune System DiseasesPremature Infant DiseaseImmunoglobulin Deficiency
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes 96
Not applicableLooking for participantsNCT06228794
What this trial is testing

The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 458
Not applicableLooking for participantsNCT06357754
What this trial is testing

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic LeukaemiaMultiple Myeloma
Bristol-Myers Squibb 50
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT02060305
What this trial is testing

Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis

Who this might be right for
HemophiliaSynovitis
National Taiwan University Hospital 5
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Large-scale testing (Phase 3)Looking for participantsNCT07518186
What this trial is testing

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 700
Post-approval studies (Phase 4)Study completedNCT01731886
What this trial is testing

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Columbia University 60
Next Page